<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier</title>
	<atom:link href="http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 09:14:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier &#124; Xconomy &#171; The Healthcare &#38; Life Sciences Venture Capital Chasm</title>
		<link>http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/comment-page-1/#comment-567356</link>
		<dc:creator>Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier &#124; Xconomy &#171; The Healthcare &#38; Life Sciences Venture Capital Chasm</dc:creator>
		<pubDate>Sun, 22 Jan 2012 13:09:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=6643#comment-567356</guid>
		<description>[...] Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier....  Share this:LinkedInEmailPrintMoreFacebookTwitterLike this:LikeBe the first to like this post. [...]</description>
		<content:encoded><![CDATA[<p>[...] Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier….  Share this:LinkedInEmailPrintMoreFacebookTwitterLike this:LikeBe the first to like this post. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier &#124; Xconomy &#171; The Healthcare &#38; Life Sciences Venture Capital Chasm</title>
		<link>http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/comment-page-1/#comment-566617</link>
		<dc:creator>Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier &#124; Xconomy &#171; The Healthcare &#38; Life Sciences Venture Capital Chasm</dc:creator>
		<pubDate>Sat, 21 Jan 2012 15:02:40 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=6643#comment-566617</guid>
		<description>[...] Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier.... Share this:LinkedInEmailPrintMoreFacebookTwitterLike this:LikeBe the first to like this post. [...]</description>
		<content:encoded><![CDATA[<p>[...] Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier…. Share this:LinkedInEmailPrintMoreFacebookTwitterLike this:LikeBe the first to like this post. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Richard</title>
		<link>http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/comment-page-1/#comment-42841</link>
		<dc:creator>Richard</dc:creator>
		<pubDate>Sun, 14 Dec 2008 07:04:25 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=6643#comment-42841</guid>
		<description>Alan is always great to listen to. Thanks, Luke.

One thing I wonder about is the sustainability of a model where a sale is the goal. Founders do well financially but often others do not. In many cases, the employees are let go, meaning they have to look for a new job. 

Would many people put in the added years of graduate school and postdocs in order to work at a biotech startup for a couple of years and then have to start over? Can we maintain the pipeline of innovative researchers needed in biotech when their only alternatives are to be scientific gypsies or to start their own startups? 

Wish I knew the answer.</description>
		<content:encoded><![CDATA[<p>Alan is always great to listen to. Thanks, Luke.</p>
<p>One thing I wonder about is the sustainability of a model where a sale is the goal. Founders do well financially but often others do not. In many cases, the employees are let go, meaning they have to look for a new job. </p>
<p>Would many people put in the added years of graduate school and postdocs in order to work at a biotech startup for a couple of years and then have to start over? Can we maintain the pipeline of innovative researchers needed in biotech when their only alternatives are to be scientific gypsies or to start their own startups? </p>
<p>Wish I knew the answer.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: So, VC&#8217;s Broke&#8230; Can We Fix It? &#171; Ask Lazlo</title>
		<link>http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/comment-page-1/#comment-42318</link>
		<dc:creator>So, VC&#8217;s Broke&#8230; Can We Fix It? &#171; Ask Lazlo</dc:creator>
		<pubDate>Mon, 08 Dec 2008 21:00:57 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=6643#comment-42318</guid>
		<description>[...] VC&#8217;s Broke&#8230; Can We Fix&#160;It? There was a terrific interview with Alan Frazier (from Frazier Healthcare Ventures) posted on Xconomy&#8217;s site.  I encourage everyone to check [...]</description>
		<content:encoded><![CDATA[<p>[...] VC’s Broke… Can We Fix It? There was a terrific interview with Alan Frazier (from Frazier Healthcare Ventures) posted on Xconomy’s site.  I encourage everyone to check [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lee Buckler</title>
		<link>http://www.xconomy.com/seattle/2008/12/04/traditional-venture-model-is-broken-for-biotech-companies-need-to-adapt-says-vc-alan-frazier/comment-page-1/#comment-42010</link>
		<dc:creator>Lee Buckler</dc:creator>
		<pubDate>Fri, 05 Dec 2008 21:55:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=6643#comment-42010</guid>
		<description>Great interview Luke and another great article.  I&#039;m loving Alan&#039;s enthusiasm for personalized medicine in the coming 5-10 years.

--Lee
www.celltherapygroup.com

p.s. Are you on Twitter?  I&#039;m @celltherapy.</description>
		<content:encoded><![CDATA[<p>Great interview Luke and another great article.  I’m loving Alan’s enthusiasm for personalized medicine in the coming 5-10 years.</p>
<p>–Lee<br />
<a href="http://www.celltherapygroup.com" rel="nofollow">http://www.celltherapygroup.com</a></p>
<p>p.s. Are you on Twitter?  I’m @celltherapy.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

